Form 8-K - Current report:
SEC Accession No. 0001558370-24-011977
Filing Date
2024-08-13
Accepted
2024-08-13 07:09:04
Documents
53
Period of Report
2024-08-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mrns-20240813x8k.htm   iXBRL 8-K 47190
2 EX-99.1 mrns-20240813xex99d1.htm EX-99.1 253234
3 EX-99.2 mrns-20240813xex99d2.htm EX-99.2 62926
4 GRAPHIC mrns-20240813xex99d1001.jpg GRAPHIC 6714
5 GRAPHIC mrns-20240813xex99d2g001.jpg GRAPHIC 252414
6 GRAPHIC mrns-20240813xex99d2g002.jpg GRAPHIC 353527
7 GRAPHIC mrns-20240813xex99d2g003.jpg GRAPHIC 123796
8 GRAPHIC mrns-20240813xex99d2g004.jpg GRAPHIC 173042
9 GRAPHIC mrns-20240813xex99d2g005.jpg GRAPHIC 175112
10 GRAPHIC mrns-20240813xex99d2g006.jpg GRAPHIC 105632
11 GRAPHIC mrns-20240813xex99d2g007.jpg GRAPHIC 209217
12 GRAPHIC mrns-20240813xex99d2g008.jpg GRAPHIC 164713
13 GRAPHIC mrns-20240813xex99d2g009.jpg GRAPHIC 137998
14 GRAPHIC mrns-20240813xex99d2g010.jpg GRAPHIC 182668
15 GRAPHIC mrns-20240813xex99d2g011.jpg GRAPHIC 161271
16 GRAPHIC mrns-20240813xex99d2g012.jpg GRAPHIC 126596
17 GRAPHIC mrns-20240813xex99d2g013.jpg GRAPHIC 175802
18 GRAPHIC mrns-20240813xex99d2g014.jpg GRAPHIC 166386
19 GRAPHIC mrns-20240813xex99d2g015.jpg GRAPHIC 161864
20 GRAPHIC mrns-20240813xex99d2g016.jpg GRAPHIC 135883
21 GRAPHIC mrns-20240813xex99d2g017.jpg GRAPHIC 162807
22 GRAPHIC mrns-20240813xex99d2g018.jpg GRAPHIC 160726
23 GRAPHIC mrns-20240813xex99d2g019.jpg GRAPHIC 202174
24 GRAPHIC mrns-20240813xex99d2g020.jpg GRAPHIC 129444
25 GRAPHIC mrns-20240813xex99d2g021.jpg GRAPHIC 108426
26 GRAPHIC mrns-20240813xex99d2g022.jpg GRAPHIC 179958
27 GRAPHIC mrns-20240813xex99d2g023.jpg GRAPHIC 125417
28 GRAPHIC mrns-20240813xex99d2g024.jpg GRAPHIC 152386
29 GRAPHIC mrns-20240813xex99d2g025.jpg GRAPHIC 171152
30 GRAPHIC mrns-20240813xex99d2g026.jpg GRAPHIC 148186
31 GRAPHIC mrns-20240813xex99d2g027.jpg GRAPHIC 209019
32 GRAPHIC mrns-20240813xex99d2g028.jpg GRAPHIC 139834
33 GRAPHIC mrns-20240813xex99d2g029.jpg GRAPHIC 104078
34 GRAPHIC mrns-20240813xex99d2g030.jpg GRAPHIC 115152
35 GRAPHIC mrns-20240813xex99d2g031.jpg GRAPHIC 124708
36 GRAPHIC mrns-20240813xex99d2g032.jpg GRAPHIC 176262
37 GRAPHIC mrns-20240813xex99d2g033.jpg GRAPHIC 77242
38 GRAPHIC mrns-20240813xex99d2g034.jpg GRAPHIC 163786
39 GRAPHIC mrns-20240813xex99d2g035.jpg GRAPHIC 34681
40 GRAPHIC mrns-20240813xex99d2g036.jpg GRAPHIC 190659
41 GRAPHIC mrns-20240813xex99d2g037.jpg GRAPHIC 191656
  Complete submission text file 0001558370-24-011977.txt   8630090

Data Files

Seq Description Document Type Size
42 EX-101.SCH mrns-20240813.xsd EX-101.SCH 3252
43 EX-101.LAB mrns-20240813_lab.xml EX-101.LAB 16590
44 EX-101.PRE mrns-20240813_pre.xml EX-101.PRE 10712
55 EXTRACTED XBRL INSTANCE DOCUMENT mrns-20240813x8k_htm.xml XML 5063
Mailing Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087
Business Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087 484-801-4670
MARINUS PHARMACEUTICALS, INC. (Filer) CIK: 0001267813 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36576 | Film No.: 241198748
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)